We further identified IRF4 as a key regulator of BCL2‐induced SOX9 expression, and ChIP‐seq confirmed that IRF4 is a key transcription factor for SOX9 in DLBCL. This evidence concerns the gene SOX9 and diffuse large B-cell lymphoma.